Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report.
De Vleeschouwer S, Van Calenbergh F, Demaerel P, Flamen P, Rutkowski S, Kaempgen E, Wolff JE, Plets C, Sciot R, Van Gool SW. De Vleeschouwer S, et al. Among authors: van gool sw, van calenbergh f. J Neurosurg. 2004 May;100(5 Suppl Pediatrics):492-7. doi: 10.3171/ped.2004.100.5.0492. J Neurosurg. 2004. PMID: 15287461
Defining pseudoprogression in glioblastoma multiforme.
Van Mieghem E, Wozniak A, Geussens Y, Menten J, De Vleeschouwer S, Van Calenbergh F, Sciot R, Van Gool S, Bechter OE, Demaerel P, Wilms G, Clement PM. Van Mieghem E, et al. Among authors: van gool s, van calenbergh f. Eur J Neurol. 2013 Oct;20(10):1335-41. doi: 10.1111/ene.12192. Epub 2013 May 17. Eur J Neurol. 2013. PMID: 23679051
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial.
Ardon H, Van Gool SW, Verschuere T, Maes W, Fieuws S, Sciot R, Wilms G, Demaerel P, Goffin J, Van Calenbergh F, Menten J, Clement P, Debiec-Rychter M, De Vleeschouwer S. Ardon H, et al. Among authors: van gool sw, van calenbergh f. Cancer Immunol Immunother. 2012 Nov;61(11):2033-44. doi: 10.1007/s00262-012-1261-1. Epub 2012 Apr 22. Cancer Immunol Immunother. 2012. PMID: 22527250 Free PMC article. Clinical Trial.
Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study.
Rutkowski S, De Vleeschouwer S, Kaempgen E, Wolff JE, Kühl J, Demaerel P, Warmuth-Metz M, Flamen P, Van Calenbergh F, Plets C, Sörensen N, Opitz A, Van Gool SW. Rutkowski S, et al. Among authors: van gool sw, van calenbergh f. Br J Cancer. 2004 Nov 1;91(9):1656-62. doi: 10.1038/sj.bjc.6602195. Br J Cancer. 2004. PMID: 15477864 Free PMC article.
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme.
De Vleeschouwer S, Fieuws S, Rutkowski S, Van Calenbergh F, Van Loon J, Goffin J, Sciot R, Wilms G, Demaerel P, Warmuth-Metz M, Soerensen N, Wolff JE, Wagner S, Kaempgen E, Van Gool SW. De Vleeschouwer S, et al. Among authors: van loon j, van gool sw, van calenbergh f. Clin Cancer Res. 2008 May 15;14(10):3098-104. doi: 10.1158/1078-0432.CCR-07-4875. Clin Cancer Res. 2008. PMID: 18483377 Free article. Clinical Trial.
148 results